Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
976
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $12.7M | 0.02% |
1,011,753
+471,312
| +87% | +$6.51M |
|
|
HTO
977
H2O America
HTO
$2.67B
| $12.7M | 0.02% |
227,468
+167,024
| +276% | +$9.91M |
|
978
YPF Sociedad Anonima ADS
YPF
$19.6B
| $12.6M | 0.02% |
943,577
+448,007
| +90% | +$6.59M |
|
979
JetBlue
JBLU
$1.92B
| $12.6M | 0.02% |
785,499
-171,891
| -18% | -$3M |
|
|
CNR
980
Core Natural Resources Inc
CNR
$4.81B
| $12.6M | 0.02% |
397,347
-38,325
| -9% | -$1.41M |
|
|
BOLD
981
DELISTED
Audentes Therapeutics, Inc
BOLD
| $12.6M | 0.02% |
+590,974
| New | +$15.2M |
|
|
FOE
982
DELISTED
Ferro Corporation
FOE
| $12.6M | 0.02% |
802,643
-326,162
| -29% | -$5.95M |
|
|
PACW
983
DELISTED
PacWest Bancorp
PACW
| $12.5M | 0.02% |
376,157
+149,732
| +66% | +$5.97M |
|
984
PUT
Eaton
ETN
$159B
| $12.5M | 0.02% |
182,100
+152,100
| +507% | +$11.4M |
|
|
ESV
985
DELISTED
Ensco Rowan plc
ESV
| $12.5M | 0.02% |
876,576
-841,641
| -49% | -$21.7M |
|
|
SRC
986
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $12.5M | 0.02% |
+353,962
| New | +$13.6M |
|
987
Flowserve
FLS
$10.2B
| $12.5M | 0.02% |
328,097
-486,023
| -60% | -$22.7M |
|
988
Emcor
EME
$32.6B
| $12.4M | 0.02% |
207,952
+57,912
| +39% | +$4.01M |
|
989
Omeros
OMER
$1.4B
| $12.4M | 0.02% |
1,112,584
+994,829
| +845% | +$13.9M |
|
990
eHealth
EHTH
$38.4M
| $12.4M | 0.02% |
321,687
-28,689
| -8% | -$965K |
|
|
TUP
991
DELISTED
Tupperware Brands Corporation
TUP
| $12.3M | 0.02% |
391,131
+286,248
| +273% | +$9.97M |
|
|
992
CALL
Starbucks
SBUX
$121B
| $12.3M | 0.02% |
191,700
+119,100
| +164% | +$7.45M |
|
993
AMN Healthcare
AMN
$1.31B
| $12.3M | 0.02% |
217,846
+206,676
| +1,850% | +$11.6M |
|
|
VTLE
994
DELISTED
Vital Energy
VTLE
| $12.3M | 0.02% |
170,468
-291,017
| -63% | -$30.5M |
|
|
SAGE
995
DELISTED
Sage Therapeutics
SAGE
| $12.3M | 0.02% |
128,822
-229,877
| -64% | -$26.3M |
|
996
First Horizon
FHN
$11.6B
| $12.3M | 0.02% |
936,964
+902,323
| +2,605% | +$14M |
|
|
HOLX
997
CALL
DELISTED
Hologic
HOLX
| $12.3M | 0.02% |
300,000
+75,000
| +33% | +$3.08M |
|
|
SIEN
998
DELISTED
Sientra, Inc.
SIEN
| $12.3M | 0.02% |
96,611
+52,216
| +118% | +$9.7M |
|
999
Wingstop
WING
$3.1B
| $12.3M | 0.02% |
191,089
+145,216
| +317% | +$9.49M |
|
1000
Avery Dennison
AVY
$13.6B
| $12.2M | 0.02% |
136,113
-277,051
| -67% | -$26.1M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.